BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Humphrey RW, Davis DA, Newcomb FM, Yarchoan R. Human herpesvirus 8 (HHV-8) in the pathogenesis of Kaposi's sarcoma and other diseases. Leuk Lymphoma 1998;28:255-64. [PMID: 9517497 DOI: 10.3109/10428199809092681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Castillo JJ, Shum H, Lahijani M, Winer ES, Butera JN. Prognosis in primary effusion lymphoma is associated with the number of body cavities involved. Leukemia & Lymphoma 2012;53:2378-82. [DOI: 10.3109/10428194.2012.694075] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
2 Morand P, Buisson M, Collandre H, Chanzy B, Genoulaz O, Bourgeat M, Pinel N, Leclercq P, Leroux D, Marechal V, Fritsch L, Ruigrok R, Seigneurin J. Human Herpesvirus 8 and Epstein Barr-Virus in a Cutaneous B-Cell Lymphoma and a Malignant Cell Line Established from the Blood of an AIDS Patient. Leukemia & Lymphoma 2009;35:379-87. [DOI: 10.3109/10428199909145743] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
3 Pérez CL, Rudoy S. Anti-CD20 monoclonal antibody treatment of human herpesvirus 8-associated, body cavity-based lymphoma with an unusual phenotype in a human immunodeficiency virus-negative patient. Clin Diagn Lab Immunol 2001;8:993-6. [PMID: 11527816 DOI: 10.1128/CDLI.8.5.993-996.2001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Brown TJ, Mccrary M, Tyring SK. Antiviral agents: Nonantiviral drugs. Journal of the American Academy of Dermatology 2002;47:581-99. [DOI: 10.1067/mjd.2002.121033] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
5 Guilluy C, Zhang Z, Bhende PM, Sharek L, Wang L, Burridge K, Damania B. Latent KSHV infection increases the vascular permeability of human endothelial cells. Blood 2011;118:5344-54. [PMID: 21881052 DOI: 10.1182/blood-2011-03-341552] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
6 Bräuninger A, Spieker T, Willenbrock K, Gaulard P, Wacker HH, Rajewsky K, Hansmann ML, Küppers R. Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma. J Exp Med 2001;194:927-40. [PMID: 11581315 DOI: 10.1084/jem.194.7.927] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 3.9] [Reference Citation Analysis]